Showing results for CTSI
Statewide institute receives $38M NIH grant to advance health research in Indiana
Indiana Clinical and Translational Sciences Institute | Mar 20, 2023
Cold Spring Harbor Laboratory researcher named 2022 Watanabe Prize winner
IU School of Medicine | Jun 16, 2022
Statewide study shows COVID-19 antibodies last longer in children than adults, but diminish over time
IU School of Medicine | Apr 28, 2022
IU School of Medicine researchers draw analogies between art and science in new study
IU School of Medicine | Feb 08, 2022
IU exceeds several underrepresented population recruitment goals in COVID-19 vaccine study
IU School of Medicine | Mar 30, 2021
Findings from asymptomatic COVID-19 study in Marion County contain important information for parents, their children
IU School of Medicine | Aug 26, 2020
IU School of Medicine announces multi-million dollar strategic research agreement with Lilly
IU School of Medicine | Jul 21, 2020
2 physician-scientists to lead Indiana Clinical and Translational Sciences Institute
IU School of Medicine | Jun 16, 2020
Researchers grow hairy skin from human stem cells
IU School of Medicine | Jun 04, 2020
IU School of Medicine researchers predict which triple negative breast cancer patients may avoid recurrence and those who are at high-risk of relapse
SAN ANTONIO — Indiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and which women are likely to remain disease-free. They will present their findings on December 13, 2019, at the San Antonio Breast Cancer Symposium, the most influential gathering of breast cancer researchers and physicians in the world. Milan Radovich, PhD, and Bryan Schneider, […]
IU School of Medicine | Dec 13, 2019